Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 101 | 176 | 364 | 281 | 219 |
| Cost of Goods | 73 | 113 | 144 | 139 | 110 |
| Gross Profit | 28 | 62 | 219 | 142 | 109 |
| Operating Expenses | 1,168 | 1,335 | 1,220 | 1,159 | 1,270 |
| Operating Income | -1,140 | -1,273 | -1,001 | -1,017 | -1,161 |
| Interest Expense | 6 | 7 | 7 | 7 | 8 |
| Other Income | 12 | 13 | 17 | 9 | 14 |
| Pre-tax Income | -1,134 | -1,267 | -991 | -1,016 | -1,155 |
| Net Income Continuous | -1,134 | -1,267 | -991 | -1,016 | -1,155 |
| Net Income | $-1,134 | $-1,267 | $-991 | $-1,016 | $-1,155 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-1,060 | $-1,192 | $-912 | $-936 | $-1,076 |